Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$1.43 +0.05 (+3.65%)
As of: Nov 11, 2026 · 2:24 PM EST

Kiora Pharmaceuticals (KPRX) Price to Earnings (2024)

Updated

Kiora Pharmaceuticals' (KPRX) Price to Earnings was 3.56 for Q4 2024, up 27.9% from the prior quarter.

Analysis

Kiora Pharmaceuticals (KPRX) Price to Earnings (2024) Analysis & Trends

Dating back to Q1 2024, Kiora Pharmaceuticals' Price to Earnings record includes 4 quarters.

  • Five-year quarterly Price to Earnings spans a low of 2.78 in Q3 2024 and a high of 6.60 in Q1 2024.
  • Per Business Quant data, the three quarters before Q4 2024 came in at 2.78 (Q3 2024), 5.47 (Q2 2024) and 6.60 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kiora Pharmaceuticals 8.53 Mn -58.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.56
Sep 30, 2024 2.78
Jun 30, 2024 6.56
Mar 31, 2024 8.14
API Access

Kiora Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=KPRX&period=max&api_key=YOUR_API_KEY